SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

biote Corp. (NASDAQ:BTMD)

US · Delayed Price · Currency is USD
1.11+0.00 (+0.00%)
 
Market Cap48.96M-61.3%
Revenue (ttm)183.53M-7.8%
Net Income5.86M-81.3%
EPS0.12-87.0%
Shares Out44.11M
PE Ratio6.61
Forward PE4.67
Dividendn/a
Ex-Dividend Daten/a
Volume20,320
Open1.10
Previous Close1.11
Day's Range1.07 - 1.12
52-Week Range1.07 - 3.26
Beta1.69
AnalystsBuy
Price Target4.00(+260.36%)
Earnings DateNov 4, 2026
+0.00% (1D)
No price history available.
Insider Score
/ 100
BTMD Insider Score

biote Corp. has a live Insider Score.

Scored on 2 qualifying trades from 1 insider in the last 90 days.

Unlock the score

About BTMD

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

Address
1875 West Walnut Hill Lane, Irving, TX, 75038, US
Market Cap
49 million
Employees
223
Industrial Classification
Medical - Care Facilities

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$202.20K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.63%
5 Days
-4.31%
1 Month
-26.49%
6 Months
-24.49%
1 Year
-61.32%

$BTMD stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BTMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BTMD's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BTMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BTMD Revenue by Segment or Geography

BTMD's latest filing doesn't break out revenue by segment.

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BTMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BTMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BTMD

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$1.36M
VXFVanguard Extended Market ETF$407.75K
DFASDimensional - US Small Cap ETF$255.50K
DFMCU.S. Micro Cap Portfolio ETF$141.79K
IWCiShares Micro-Cap ETF$95.92K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$40.00K

Estimated from each fund’s disclosed top holdings × AUM

BTMD Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for BTMD is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from BTMD’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
2
Sells
0
Buy Value
$202.20K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.